Fact CheckerSign in

NCT06224426Recruiting

Oxygen Concentration Target in Stroke Endovascular Treatment

Oxygenation Targets for Endovascular Therapy in Acute Ischemic Stroke Patients (Oxy-TARGET)

Source: ClinicalTrials.gov · Last updated 2 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this clinical trial is to compare the effects of different concentrations of normobaric oxygen on early neurological improvement in acute ischemic stroke (AIS) patients receiving endovascular therapy (EVT). The main questions it aims to answer are: * Evaluating the impact of normobaric high-concentration oxygen versus low-concentration oxygen on early neurological function after EVT. * Evaluating the safety of high and low normobaric oxygen concentration in patients with ischemic stroke. Participants will (1) receive EVT under general anesthesia; (2) be randomly assigned 1:1 to receive oxygen therapy with FiO2=80% or FiO2=30% through endotracheal intubation during the operation, and the gas flow rate was set at 4L /min.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
200 (estimated)
First submitted
17 Dec 2023
Start date
1 Feb 2024
Primary completion date
30 Sept 2026
Lead sponsor
Beijing Tiantan Hospital
Diseases
Stroke
NCT number
NCT06224426

What you commit to

  • Study type: Interventional
  • Planned participants: 200
  • From 1 Feb 2024 to the primary completion date, 30 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Stroke onset within 6-24 hours with a CT perfusion imaging (CTP)-assessed mismatched area\<15 ml.
  • Pre-stroke modified Rankin scale (mRS) score ≥2.
  • Complicated by severe agitation and seizures.
  • Evidence of intracranial hemorrhage at admission.
  • Presence of chronic obstructive pulmonary disease, asthma, or other respiratory conditions, or requirement for daily supplemental oxygen or mechanical ventilation.
  • Emergency chest CT reveals significant pulmonary parenchymal infection.

Lab values

  • Presence of anemia, defined as hemoglobin levels o below 120 g/L in men and below 110 g/L in women.

Other

  • Baseline arterial blood gas analysis indicating impaired gas exchange: PaO2 \< 60 mmHg on room air, or oxygenation index (PaO2/FiO2) \< 300 mmHg with supplemental oxygen.
  • An oxygen mask or ventilator must be used before anesthesia to maintain a SpO2≥94%.
  • Loss of airway protective reflex or vomiting aspiration upon admission.

Who the study is looking for

  • Age ≥18 years.
  • Anterior circulation occlusive stroke is confirmed by CT angiography (CTA), magnetic resonance angiography (MRA) or digital subtraction angiography (DSA), and occlusions of intracranial internal carotid artery (ICA) or M1 segment of the middle cerebral artery (MCA) were involved.
  • NIHSS score at admission: 6-20.
  • Randomization can be completed within 24 hours after stroke onset.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beijing Tiantan Hospital,Capital Medical University
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.